CCSD code G8080 – Small bowel capsule endoscopy

Key takeaways

CCSD code G8080, small bowel capsule endoscopy including interpretation and evaluation, is inactivated and should not appear on new private claims.

CCSD Bulletin 196 inactivated G8080 with a recommended adoption date of 8 August 2024, alongside the upper GI (G8081) and colon (G8086) capsule codes.

The same bulletin added G8087, Capsule endoscopy of GI system, which is the current CCSD code for billing capsule endoscopy.

Prior authorisation, a documented indication, failed prior investigations and a dated consultant report still decide whether a capsule endoscopy claim gets paid.

Pabau, our practice management platform, supports CCSD code entry and Healthcode claims, so practices can swap G8080 for G8087 before the next claim goes out.

What CCSD code G8080 covered and why it is inactivated

CCSD code G8080 was the Clinical Coding and Schedule Development (CCSD) code for small bowel capsule endoscopy, including interpretation and evaluation. It is no longer an active code.

The CCSD Working Group inactivated G8080 in CCSD Bulletin 196, dated 13 June 2024. The bulletin gives a recommended adoption date of 8 August 2024, and says the changes may be implemented before then.

The same bulletin inactivated the two sibling capsule codes: G8081 for upper GI capsule endoscopy and G8086 for colon capsule endoscopy. It also added one new code, G8087, Capsule endoscopy of GI system.

The CCSD schedule is maintained by the CCSD Group, a joint body representing UK medical associations and private insurers. CCSD codes are alphanumeric: one letter followed by four digits. The letter denotes the body system, and G8080 sits in Chapter 10, Endoscopic gastrointestinal tract. Neighbouring endoscopy procedures are listed in our searchable CCSD library.

G8080 code details at a glance

Is G8080 still valid? Code status and the 2024 inactivation

No. G8080 is listed under Inactivation in CCSD Bulletin 196, so it should not be used for capsule endoscopy performed after the change was adopted.

The bulletin sets a recommended adoption date rather than a fixed cut-off. For episodes dated around August 2024, check which code each insurer accepted at the time.

For capsule endoscopy carried out today, a claim carrying G8080 is likely to come back as an invalid code. Update the code in your fee schedule and service list before the next claim goes out.

Replacement code: What to bill instead of G8080

Bill G8087, Capsule endoscopy of GI system, for capsule endoscopy. The bulletin that inactivated G8080 added G8087 at the same time, with the same recommended adoption date.

The G8087 narrative names the GI system as a whole, not one segment of it. In practice, that single code takes the place of the three regional capsule codes the bulletin retired, as the diagram shows.

Unlike G8080, the G8087 narrative does not say whether interpretation and evaluation are included. Check the current CCSD schedule or your insurer’s fee schedule for its inclusions and fee before you apply the old bundling rules.

Neighbouring codes and how to avoid confusion

Four CCSD codes cover capsule endoscopy, and three of them are now inactive. The table below sets out how each one relates to G8080. US practices bill the same test under CPT 91110, which never appears on a UK private claim.

What the procedure involves

Capsule endoscopy uses a swallowable wireless camera capsule to image the gut. Each step below feeds both the clinical record and the documentation a billing team needs.

1. Patient preparation: The patient fasts beforehand, usually overnight. Bowel preparation may be prescribed by the treating gastroenterologist, depending on the clinical indication.
2. Sensor belt attachment: Electrode leads or a recorder belt is placed on the abdomen to receive image data from the capsule throughout transit.
3. Capsule ingestion: The patient swallows the PillCam SB or an equivalent device, which starts transmitting images straight away. The consultant or specialist nurse confirms ingestion and records the capsule serial number.
4. Transit period: The capsule travels through the oesophagus, stomach and small bowel towards the caecum. Capsule battery life is typically about 8 to 12 hours, and transit time varies by patient. Gastric and small bowel transit times are recorded from the data file.
5. Device retrieval: The recorder belt is returned at the end of the study. The capsule passes naturally and does not need to be retrieved.
6. Image review and report: The gastroenterologist reviews the full image sequence, records findings and writes a date-stamped report. Under G8080 this step was part of the code; check how your insurer treats it under G8087.

Clinical indications for small bowel capsule endoscopy

Private medical insurers require documented medical necessity before they pay for capsule endoscopy. Accepted indications generally follow British Society of Gastroenterology (BSG) guidance on its appropriate use.

• Obscure gastrointestinal bleeding (OGIB): The most common indication. It covers overt and occult bleeding where upper and lower endoscopy have not found a source.
• Iron deficiency anaemia of unknown origin: After gastroscopy and colonoscopy have excluded upper and lower GI causes.
• Suspected Crohn’s disease of the small bowel: Where ileocolonoscopy is inconclusive and small bowel imaging is needed.
• Polyposis syndromes: Including Peutz-Jeghers syndrome surveillance, where small bowel polyps need monitoring.
• Coeliac disease monitoring: In non-responsive or refractory coeliac disease, where the mucosa beyond the duodenum needs assessing.

Payers typically expect evidence that conventional investigations came first and did not find the source. Missing evidence is a common cause of denial, so record prior investigations in the referral letter and procedure notes.

What G8080 included and what it did not

The G8080 narrative bundled the capsule study with its interpretation and evaluation. The table shows what the narrative settles and what it leaves to the CCSD principles. That boundary still matters when you review or appeal claims raised under the old code.

Refer to the CCSD Technical Guide for the general coding rules, and check how G8087 is described in the current schedule. Individual insurer fee schedules may add further restrictions.

Documentation requirements for a capsule endoscopy claim

A complete procedure record is the strongest defence against denial. Each element below should appear in the clinical notes before the claim is submitted. Practices using digital clinical forms can build these fields into one capsule endoscopy template, so none is missed at the point of care.

• Clinical indication: The documented reason for the procedure, including the diagnosis code or clinical description.
• Prior investigations: Named procedures performed before capsule endoscopy and their results, confirming no alternative source was found.
• Referring and treating consultant: Full name and GMC number of the consultant who ordered and reported the procedure.
• Capsule device details: Manufacturer, model (e.g. PillCam SB3) and serial number of the device used.
• Sensor placement and recorder details: Recording device identifier and confirmation of electrode placement.
• Transit times: Gastric and small bowel transit times, or a note that the capsule did not reach the caecum.
• Image count reviewed: Total number of frames captured and reviewed.
• Interpretation narrative: The consultant’s written findings for each bowel segment, including abnormalities, landmarks and diagnostic conclusions.
• Procedure report date: The date the report was generated and signed, which may differ from the procedure date.

Capsule endoscopy prior authorisation: Which insurers require it

Most UK private medical insurers require prior authorisation before they pay for capsule endoscopy. The authorisation reference must appear on the claim form. Claims without it may be rejected, so confirm each insurer’s process.

Make sure the authorisation request names G8087, not G8080, so the reference matches the code on the claim.

Requirements vary by insurer and policy year, so confirm the current position with each payer before scheduling. Major PMI providers known to apply pre-authorisation to specialist investigations like this include Bupa, AXA Health, Vitality Health and Aviva Health. Practices billing several insurers benefit from one standard way of tracking authorisation references.

The typical prior authorisation process follows these steps:

1. Referral letter prepared: The referring GP or specialist documents the indication, prior investigations and why capsule endoscopy is appropriate. This forms the basis of the request.
2. Submission to insurer: The letter and supporting results go through the insurer’s authorisation portal or by telephone. Some insurers accept direct submission from the treating gastroenterologist.
3. Authorisation reference issued: If approved, the insurer issues a reference number tied to the patient’s policy and the specific procedure.
4. Reference recorded on claim: The reference is recorded in the practice management system and added to the claim form. Without it, the claim may be rejected.

Why capsule endoscopy claims get denied and how to prevent it

Capsule endoscopy denials follow predictable patterns. Most are preventable with a structured pre-submission check.

• Inactive code on the claim: G8080 is inactivated, so a claim that still carries it is likely to be returned. Bill G8087 instead.
• Missing prior authorisation reference: The claim form must carry the insurer-issued authorisation number. If authorisation was not obtained before the procedure, the claim may not be recoverable.
• Insufficient indication documentation: A diagnosis code alone is not enough. Insurers expect a clinical narrative showing why capsule endoscopy was the right next investigation.
• Same-day bundling without justification: Billing capsule endoscopy and a colonoscopy on the same date without insurer-approved justification often triggers a denial or clinical review. Bundling rules differ by insurer, so confirm first.
• Incomplete or illegible procedure report: A report missing the interpretation narrative, a date stamp or the reporting clinician’s GMC number will fail medical records review.
• Capsule retention handled incorrectly: The completed study is still billed when retention occurs. Record the retention separately rather than folding it into the capsule endoscopy line.
• Late submission: Most UK PMI providers set a claims submission deadline. Check each insurer’s limit, as late claims are usually declined regardless of clinical merit.

Capsule retention: Coding the complication

Capsule retention occurs when the device does not pass through the gut within the expected timeframe, most often because of an unsuspected stricture. Published studies report retention in roughly 1 to 2 percent of small bowel studies.

Rates are higher in patients with known or suspected Crohn’s disease. Retention does not invalidate the capsule endoscopy claim, because the consultant still reviewed the images captured before the capsule stopped.

Handle the retention event like this:

1. Code the procedure: Submit the current capsule endoscopy code, G8087, for the completed study. G8080 applies only to episodes before your insurer adopted the change.
2. Record the complication separately: Capture the retained capsule as a diagnosis in the notes and on the claim. Any later retrieval is a separate procedure with its own CCSD code.
3. Document the retention: The procedure report must note that the capsule had not passed at the time of reporting, and include the clinical management plan.

Billing CCSD capsule endoscopy codes in practice management software

A code change like this one is easiest to absorb when CCSD codes and insurer claims live in one system. Pabau handles CCSD code entry and submits claims to UK private medical insurers through Healthcode.

Billing teams update the capsule endoscopy service to G8087 once, then log each prior authorisation reference against the patient’s episode. Pabau’s claims management software pulls the details already on the patient record into the claim, then tracks it through Healthcode.

For gastroenterology practices running several capsule studies a week, the gain is in the pre-submission workflow. Each claim can be checked against the documentation checklist, with the authorisation reference and consultant GMC number confirmed in one place.

The same workflow covers Bupa CCSD codes and the other major UK PMI providers. Patient records sit alongside billing, so procedure reports and insurer letters stay against the same patient episode.

Manage CCSD billing and private insurer claims from one system

Pabau helps gastroenterology and private practice teams track CCSD codes, record authorisation references, and submit clean claims to UK private medical insurers without chasing paperwork.

Book a demo

Conclusion

G8080 is a retired code, and the fix is simple once you know it. CCSD Bulletin 196 inactivated it with a recommended adoption date of 8 August 2024, and G8087 is now the code for capsule endoscopy.

The bigger risk is an old code sitting quietly in a fee schedule or saved service list. Update it once, then keep authorisation references, indications and dated reports complete on every claim. To see how Pabau handles CCSD code workflows and private insurer claims, book a demo.

Continue your research

Billing other CCSD codes for private insurers? Bupa CCSD codes and billing guide covers the Bupa procedure code schedule and submission requirements.

Billing capsule endoscopy for US patients? CPT code 91110: Capsule endoscopy billing explains the US code, rates and documentation rules.

Coding a lower GI scope instead? CCSD code H2510: Rigid sigmoidoscopy covers rigid sigmoidoscopy with proctoscopy and biopsy.

Want to reduce claim rejection rates across your practice? Claims management software shows how Pabau builds claims from the patient record and tracks them.

Frequently asked questions